CN Patent

CN112236142A — 用于缓释递送丁丙诺啡的药物组合物

Assigned to Foresee Pharmaceuticals Co Ltd · Expires 2021-01-15 · 5y expired

What this patent protects

本发明涉及一种用于缓释递送丁丙诺啡的储库组合物，其稳定性和生物利用度增强。所述组合物为可注射的低粘度液体，并且可以原位形成能够在一周到3个月的时间段内递送治疗水平的丁丙诺啡的储库。

USPTO Abstract

本发明涉及一种用于缓释递送丁丙诺啡的储库组合物，其稳定性和生物利用度增强。所述组合物为可注射的低粘度液体，并且可以原位形成能够在一周到3个月的时间段内递送治疗水平的丁丙诺啡的储库。

Drugs covered by this patent

Patent Metadata

Patent number
CN112236142A
Jurisdiction
CN
Classification
—
Expires
2021-01-15
Drug substance claim
No
Drug product claim
No
Assignee
Foresee Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.